voriconazole has been researched along with Critical Illness in 42 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 12 (28.57) | 29.6817 |
2010's | 22 (52.38) | 24.3611 |
2020's | 8 (19.05) | 2.80 |
Authors | Studies |
---|---|
Argaud, L; Aubrun, F; Bienvenu, AL; Chidiac, C; Fellahi, JL; Gagnieu, MC; Goutelle, S; Leboucher, G; Leclerc, V; Menotti, J; Parant, F; Piriou, V; Plesa, A; Pradat, P; Richard, JC; Rimmelé, T; Tod, M | 1 |
Feih, J; Juul, J; Vu, T | 1 |
Lu, F; Wang, B; Wang, Y; Xu, Y; Zhang, L; Zhang, M | 1 |
Liu, G; Qi, Y | 1 |
Argaud, L; Aubrun, F; Bienvenu, AL; Chidiac, C; Fellahi, JL; Friggeri, A; Guerin, C; Guichon, C; Hernu, R; Leboucher, G; Menotti, J; Monard, C; Paulus, S; Piriou, V; Pradat, P; Rimmele, T | 1 |
Chen, T; Gao, L; Li, H; Li, M; Li, Q; Qiang, W; Shi, Q; Wang, J; Wang, T; Wang, Y; Yan, J; Zhang, Y; Zheng, J; Zhou, L | 1 |
Chittick, PJ; Peterson, EL; Richardson, CL | 1 |
Chandrasekar, P; Pasula, S | 1 |
Bassetti, M; Bouza, E | 1 |
Blot, S; Bulpa, P; Dimopoulos, G; Forêt, F; Frantzeskaki, F; Kosmopoulos, M; Taccone, FS; Van den Abeele, AM; Vogelaers, D | 1 |
Blot, S; Bulpa, P; Dimopoulos, G; Gomes, A; Meersseman, W; Mergulhão, P; Misset, B; Paiva, JA; Rello, J; Taccone, FS; Van den Abeele, AM; Vogelaers, D | 1 |
Ashworth, A; Barker, J; Felton, TW; Foden, P; Geraghty, CG; Muldoon, EG; Richardson, MD; Rodriguez-Goncer, I; Thomas, S | 1 |
Foerster, KI; Mahmoudi, M; Mikus, G; Seeßle, J; Vay, M | 1 |
Castellanos-Ortega, Á; Gordon, M; Marqués, MR; Peruccioni, M; Poveda-Andrés, JL; Ramirez, P; Ruiz, J; Villarreal, E | 1 |
Alastruey-Izquierdo, A; Calabuig, E; Frasquet, J; López-Hontangas, JL; Martínez, H; Mollar, J; Moret, AM; Pemán, J; Ramírez, P; Ruiz-Gaitán, A; Salavert-Lletí, M; Tasias, M; Zaragoza, Ó | 1 |
Pea, F | 1 |
Blot, SI; Charles, PE; Dimopoulos, G; Martin, C; Meersseman, W; Pérez, M; Rao, R; Rello, J; Spapen, H; Spapen, J; Taccone, FS; Vogelaers, D | 1 |
Annaert, P; de Loor, H; Lagrou, K; Maertens, J; Spriet, I; Vanstraelen, K; Vercammen, I; Wauters, J | 1 |
Aquilante, CL; Fish, DN; Kiser, TH; MacLaren, R; Rower, JE; Teitelbaum, I; Wempe, MF | 1 |
Akers, KS; Chung, KK; Graybill, JC; Mende, K; Murray, CK; Niece, KL; Rowan, MP | 1 |
Cai, S; Chen, W; Li, Y; Liang, F; Liu, X; Meng, D; Rui, J; Xiao, X; Xie, H; Yin, X; Zhang, T | 1 |
Bakker, J; Egal, M; Hunfeld, NG; Koch, BC; van Gelder, T; van Schaik, RH; Weigel, JD | 1 |
Beitz, A; Ehmer, U; Eser, S; Fekecs, L; Huber, W; Lahmer, T; Messer, M; Schmid, RM | 1 |
Chakrabarti, A; Chakravarty, C; Dutta, S; Gopalakrishnan, R; Jessani, LG; Jillwin, J; Roy, U; Rudramurthy, SM | 1 |
Annaert, P; Hermans, G; Meersseman, P; Meersseman, W; Spriet, I; Verbesselt, R; Willems, L | 1 |
Chemaissani, A; Ernestus, K; Kamp, M; Knüttgen, D; Matten, J; Sakka, SG; Ströhlein, M; Wappler, F | 1 |
Baltopoulos, G; Despotelis, S; Evaggelopoulou, P; Evodia, E; Markantonis, SL; Myrianthefs, P; Panidis, D | 1 |
Burhenne, J; Burkhardt, O; Kielstein, JT; Thon, S; Welte, T | 1 |
Böhme, A; Heinz, WJ; Silling, G | 1 |
Chvojka, J; Karvunidis, T; Krouzecky, A; Matejovic, M; Novak, I; Radej, J; Stehlik, P; Sykora, R | 1 |
Auzinger, G; Borges Sá, M; Dimopoulos, G; Grigoras, I; Kantecki, M; Marček, T; Meersseman, W; Menichetti, F; Miller, PJ; Montravers, P; Pachl, J; Paiva, JA; Ruhnke, M; Sganga, G | 1 |
Annaert, P; Brüggemann, RJ; Lagrou, K; Meersseman, P; Spriet, I; Van Wijngaerden, E; Willems, L | 1 |
Mohammedi, I; Padoin, C; Piens, MA; Robert, D | 1 |
Allepuz-Palau, A; Alvarez-Lerma, F; Díaz-Regañón, J; García-López, F; Nicolás-Arfelis, JM; Rodríguez-Borregán, JC; Sa-Borges, M | 1 |
Pemán, J; Zaragoza, R | 1 |
Burhenne, J; von Mach, MA; Weilemann, LS | 1 |
Eichhorn, ME; Hartl, WH; Jauch, KW; Joka, M; Küchenhoff, H; Wolf, H | 1 |
Fuhrmann, V; Holzinger, U; Jaeger, W; Kitzberger, R; Kneidinger, N; Miksits, M; Schenk, P; Thalhammer, F; Warszawska, J | 1 |
Alffenaar, JW; Doedens, RA; Groninger, E; Kosterink, JG | 1 |
Arnaud, P; Desmonts, JM; Lasocki, S; Massias, L; Montravers, P; Papy, E; Quintard, H | 1 |
Allepuz-Palau, A; Alvarez-Lerma, F; Angeles Leon, M; Garcia, MP; Iruretagoyena, JR; Luque-Gomez, P; Navarro, A; Sanchez-Ruiz, H | 1 |
Joshi, R; Kohli, V; Sachdev, P; Taneja, V | 1 |
3 review(s) available for voriconazole and Critical Illness
Article | Year |
---|---|
Invasive mould infections in the ICU setting: complexities and solutions.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; beta-Glucans; Critical Illness; Galactose; Humans; Immunocompromised Host; Intensive Care Units; Invasive Fungal Infections; Lung Diseases, Fungal; Mannans; Mucor; Mucormycosis; Nitriles; Opportunistic Infections; Pyridines; Respiratory System; Triazoles; Voriconazole | 2017 |
Current pharmacological concepts for wise use of echinocandins in the treatment of Candida infections in septic critically ill patients.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Critical Illness; Drug Administration Schedule; Drug Dosage Calculations; Drug Therapy, Combination; Echinocandins; Humans; Practice Guidelines as Topic; Pyrimidines; Sepsis; Triazoles; Voriconazole | 2013 |
Invasive fungal infections in critically ill patients: different therapeutic options and a uniform strategy.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Critical Illness; Cross Infection; Deoxycholic Acid; Drug Combinations; Fluconazole; Humans; Intensive Care Units; Mycoses; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2006 |
6 trial(s) available for voriconazole and Critical Illness
Article | Year |
---|---|
Population Pharmacokinetics in China: The Dynamics of Intravenous Voriconazole in Critically Ill Patients with Pulmonary Disease.
Topics: Administration, Intravenous; Adult; Aged; Aged, 80 and over; Antifungal Agents; Chemical and Drug Induced Liver Injury; China; Computer Simulation; Critical Illness; Female; Humans; Lung Diseases; Male; Middle Aged; Models, Biological; Monte Carlo Method; Voriconazole; Young Adult | 2015 |
Utilisation, efficacy and safety of voriconazole: prospective, non-interventional study on treatment of IFIs in clinical practice.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Child; Child, Preschool; Critical Illness; Female; Humans; Infant; Injections, Intravenous; Male; Middle Aged; Mycoses; Professional Practice; Prospective Studies; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2011 |
Pharmacokinetic evaluation of voriconazole treatment in critically ill patients undergoing continuous venovenous hemofiltration.
Topics: Anti-Infective Agents; Area Under Curve; Critical Illness; Drug Monitoring; Half-Life; Hemofiltration; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2011 |
Anidulafungin for the treatment of candidaemia/invasive candidiasis in selected critically ill patients.
Topics: Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Candida; Candidiasis, Invasive; Critical Illness; Drug-Related Side Effects and Adverse Reactions; Echinocandins; Female; Fluconazole; Humans; Male; Middle Aged; Prospective Studies; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2012 |
Plasma levels of voriconazole administered via a nasogastric tube to critically ill patients.
Topics: Aged; Antifungal Agents; Critical Illness; Female; Humans; Intubation, Gastrointestinal; Male; Middle Aged; Mycoses; Prospective Studies; Pyrimidines; Triazoles; Voriconazole | 2005 |
Clinical use and tolerability of voriconazole in the treatment of fungal infections in critically ill patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Critical Illness; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Fungemia; Humans; Intensive Care Units; Logistic Models; Male; Maximum Tolerated Dose; Middle Aged; Probability; Prospective Studies; Pyrimidines; Risk Assessment; Single-Blind Method; Statistics, Nonparametric; Survival Rate; Treatment Outcome; Triazoles; Voriconazole | 2005 |
33 other study(ies) available for voriconazole and Critical Illness
Article | Year |
---|---|
Association between voriconazole exposure and Sequential Organ Failure Assessment (SOFA) score in critically ill patients.
Topics: Antifungal Agents; Critical Illness; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Female; France; Humans; Intensive Care Units; Male; Middle Aged; Retrospective Studies; Risk Factors; Voriconazole | 2021 |
Fluctuating Voriconazole Concentrations during Extracorporeal Membrane Oxygenation.
Topics: Adult; Critical Illness; Extracorporeal Membrane Oxygenation; Female; Humans; Intensive Care Units; Respiratory Distress Syndrome; Voriconazole; Young Adult | 2023 |
Surveillance Study of Epidemiology, Antifungal Susceptibility and Risk Factors of Invasive Candidiasis in Critically ill Patients.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Candidiasis, Invasive; Critical Illness; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Risk Factors; Voriconazole | 2022 |
A UPLC-MS/MS method for simultaneous determination of eight special-grade antimicrobials in human plasma and application in TDM.
Topics: Anti-Infective Agents; Chromatography, High Pressure Liquid; Chromatography, Liquid; Critical Illness; Drug Monitoring; Humans; Imipenem; Linezolid; Meropenem; Micafungin; Reproducibility of Results; Tandem Mass Spectrometry; Teicoplanin; Tigecycline; Vancomycin; Voriconazole | 2022 |
Evaluation of first-line therapies for the treatment of candidemia in ICU patients: A propensity score analysis.
Topics: Aged; Antifungal Agents; Candidemia; Caspofungin; Cohort Studies; Critical Illness; Female; Fluconazole; Humans; Intensive Care Units; Kaplan-Meier Estimate; Male; Middle Aged; Propensity Score; Retrospective Studies; Treatment Outcome; Voriconazole | 2020 |
Voriconazole therapeutic drug monitoring in critically ill patients improves efficacy and safety of antifungal therapy.
Topics: Administration, Intravenous; Age Factors; Aged; Antifungal Agents; China; Chromatography, High Pressure Liquid; Critical Illness; Drug Monitoring; Female; Humans; Male; Middle Aged; Mycoses; Patient Safety; Predictive Value of Tests; Retrospective Studies; Risk Assessment; Risk Factors; Serum Albumin, Human; Sex Factors; Voriconazole | 2020 |
Decreasing voriconazole requirement in a patient after extracorporeal membrane oxygenation discontinuation: A case report.
Topics: Critical Illness; Extracorporeal Membrane Oxygenation; Humans; Male; Voriconazole | 2021 |
Spontaneous Hemoptysis in a Patient With COVID-19.
Topics: Aged; Antifungal Agents; Aspergillus niger; Clinical Deterioration; COVID-19; Critical Illness; Critical Pathways; Diagnosis, Differential; Hemoptysis; Humans; Invasive Pulmonary Aspergillosis; Lung; Male; Pseudomonas aeruginosa; Radiography, Thoracic; Respiration, Artificial; SARS-CoV-2; Superinfection; Tomography, X-Ray Computed; Treatment Outcome; Voriconazole | 2021 |
Endomyocardial and pericardial aspergillosis in critically ill patients.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Critical Illness; Echinocandins; Female; Heart Diseases; Humans; Immunocompetence; Immunocompromised Host; Incidence; Invasive Fungal Infections; Lipopeptides; Male; Middle Aged; Myocardium; Pericardium; Risk Factors; Voriconazole | 2017 |
Drivers and impact of antifungal therapy in critically ill patients with Aspergillus-positive respiratory tract cultures.
Topics: Aged; Amphotericin B; Antifungal Agents; Aspergillus; Clinical Decision-Making; Critical Illness; Delayed Diagnosis; Drug Therapy, Combination; Echinocandins; Female; Fungal Proteins; Humans; Intensive Care Units; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Prognosis; Respiratory System; Treatment Outcome; Voriconazole | 2017 |
Invasive pulmonary aspergillosis is associated with adverse clinical outcomes in critically ill patients receiving veno-venous extracorporeal membrane oxygenation.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillus; Critical Illness; Echinocandins; Extracorporeal Membrane Oxygenation; Female; Galactose; Humans; Immunocompromised Host; Influenza, Human; Invasive Pulmonary Aspergillosis; Lipopeptides; Male; Mannans; Micafungin; Middle Aged; Retrospective Studies; Risk Factors; Treatment Outcome; Voriconazole; Young Adult | 2018 |
No alteration of voriconazole concentration by plasmapheresis in a critically ill patient.
Topics: Aged; Antifungal Agents; Critical Illness; Female; Granulomatosis with Polyangiitis; Humans; Invasive Pulmonary Aspergillosis; Plasmapheresis; Voriconazole | 2019 |
Impact of voriconazole plasma concentrations on treatment response in critically ill patients.
Topics: Antifungal Agents; Bilirubin; Critical Illness; Female; Humans; Intensive Care Units; Male; Middle Aged; Plasma; Prospective Studies; Voriconazole | 2019 |
Detection and treatment of Candida auris in an outbreak situation: risk factors for developing colonization and candidemia by this new species in critically ill patients.
Topics: Adult; Aged; Antifungal Agents; Candida; Candidemia; Case-Control Studies; Critical Illness; Disease Outbreaks; Drug Resistance, Viral; Female; Fluconazole; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Risk Factors; Voriconazole | 2019 |
Cerebral aspergillosis in adult critically ill patients: a descriptive report of 10 patients from the AspICU cohort.
Topics: Adult; Aged; Antifungal Agents; Aspergillus; Brain; Cohort Studies; Critical Illness; Female; Humans; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Neuroaspergillosis; Pyrimidines; Risk Factors; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2014 |
Impact of hypoalbuminemia on voriconazole pharmacokinetics in critically ill adult patients.
Topics: Aged; Antifungal Agents; Bilirubin; Blood Proteins; Chromatography, Liquid; Critical Illness; Female; Humans; Hypoalbuminemia; Intensive Care Units; Invasive Pulmonary Aspergillosis; Liver Function Tests; Male; Middle Aged; Prospective Studies; Protein Binding; Serum Albumin; Tandem Mass Spectrometry; Voriconazole | 2014 |
Evaluation of sulfobutylether-β-cyclodextrin (SBECD) accumulation and voriconazole pharmacokinetics in critically ill patients undergoing continuous renal replacement therapy.
Topics: Adult; Antifungal Agents; beta-Cyclodextrins; Critical Illness; Humans; Kidney Failure, Chronic; Male; Middle Aged; Prospective Studies; Renal Replacement Therapy; Therapeutics; Voriconazole | 2015 |
Antifungal wound penetration of amphotericin and voriconazole in combat-related injuries: case report.
Topics: Adult; Amphotericin B; Amputation, Surgical; Antifungal Agents; Aspergillosis; Blast Injuries; Burns; Critical Illness; Debridement; Drug Monitoring; Fusariosis; Humans; Male; Mucormycosis; Mycoses; Voriconazole; War-Related Injuries; Wounds, Penetrating | 2015 |
Gain-of-function single nucleotide variants of the CYP2C19 gene (CYP2C19*17) can identify subtherapeutic voriconazole concentrations in critically ill patients: a case series.
Topics: Antifungal Agents; Aspergillosis; Critical Illness; Cytochrome P-450 CYP2C19; Genotype; Humans; Phenotype; Polymorphism, Single Nucleotide; Retrospective Studies; Voriconazole | 2015 |
Pseudallescheria boydii with Aspergillus fumigatus and Aspergillus terreus in a Critically Ill Hematopoietic Stem Cell Recipient with ARDS.
Topics: Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; beta-Glucans; Clarithromycin; Coinfection; Critical Illness; Extracorporeal Membrane Oxygenation; Galactose; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Linezolid; Male; Mannans; Meropenem; Pneumonia; Pseudallescheria; Severe Acute Respiratory Syndrome; Thienamycins; Transplant Recipients; Voriconazole | 2016 |
Seven cases of Saccharomyces fungaemia related to use of probiotics.
Topics: Adult; Aged; Amplified Fragment Length Polymorphism Analysis; Antifungal Agents; Critical Illness; Drug Resistance, Fungal; Echinocandins; Female; Fungemia; Humans; India; Infant, Newborn; Male; Microbial Sensitivity Tests; Multigene Family; Probiotics; RNA, Ribosomal; Saccharomyces boulardii; Saccharomyces cerevisiae; Voriconazole | 2017 |
Pharmacokinetics of caspofungin and voriconazole in critically ill patients during extracorporeal membrane oxygenation.
Topics: Adolescent; Adult; Antifungal Agents; Caspofungin; Critical Illness; Echinocandins; Extracorporeal Membrane Oxygenation; Humans; Lipopeptides; Male; Plasma; Pyrimidines; Triazoles; Voriconazole | 2009 |
[Invasive pulmonary aspergillosis. Occurrence in a non-neutropenic female patient with abdominal sepsis].
Topics: Abdomen; Antifungal Agents; Caspofungin; Colonic Neoplasms; Critical Illness; Echinocandins; Female; Humans; Invasive Pulmonary Aspergillosis; Laparotomy; Lipopeptides; Middle Aged; Peritonitis; Physical Therapy Modalities; Postoperative Complications; Pyrimidines; Sepsis; Triazoles; Voriconazole | 2009 |
Monitoring plasma voriconazole levels following intravenous administration in critically ill patients: an observational study.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Critical Illness; Drug Monitoring; Female; Humans; Injections, Intravenous; Kidney; Kidney Function Tests; Liver; Liver Function Tests; Male; Middle Aged; Plasma; Prospective Studies; Pyrimidines; Triazoles; Voriconazole | 2010 |
Sulphobutylether-beta-cyclodextrin accumulation in critically ill patients with acute kidney injury treated with intravenous voriconazole under extended daily dialysis.
Topics: Aged; Animals; Antifungal Agents; beta-Cyclodextrins; Critical Illness; Female; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Renal Dialysis; Renal Insufficiency; Triazoles; Voriconazole | 2010 |
Pharmacokinetic profile of voriconazole in a critically ill patient on therapeutic plasma exchange.
Topics: Antifungal Agents; Antiphospholipid Syndrome; Critical Illness; Humans; Male; Middle Aged; Plasma Exchange; Plasmapheresis; Pyrimidines; Triazoles; Voriconazole | 2013 |
Accumulation of the solvent vehicle sulphobutylether beta cyclodextrin sodium in critically ill patients treated with intravenous voriconazole under renal replacement therapy.
Topics: Aged; Antifungal Agents; beta-Cyclodextrins; Critical Illness; Female; Humans; Pyrimidines; Renal Insufficiency; Renal Replacement Therapy; Solvents; Triazoles; Voriconazole | 2006 |
Secular trends in severe renal failure associated with the use of new antimicrobial agents in critically ill surgical patients.
Topics: Acetamides; Adult; Aged; Anti-Infective Agents; Caspofungin; Cohort Studies; Critical Illness; Echinocandins; Female; Humans; Intensive Care Units; Linezolid; Lipopeptides; Male; Middle Aged; Oxazolidinones; Peptides, Cyclic; Postoperative Complications; Pyrimidines; Renal Insufficiency; Renal Replacement Therapy; Retrospective Studies; Triazoles; Voriconazole | 2007 |
Pharmacokinetics of voriconazole during continuous venovenous haemodiafiltration.
Topics: Acute Kidney Injury; Adult; Aged; Antifungal Agents; Area Under Curve; Critical Illness; Female; Half-Life; Hemodiafiltration; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2007 |
High-dose voriconazole in a critically ill pediatric patient with neuroblastoma.
Topics: Antifungal Agents; Candidiasis; Child, Preschool; Critical Illness; Humans; Lung Diseases; Male; Neuroblastoma; Pyrimidines; Triazoles; Voriconazole | 2008 |
The pharmacokinetic profile of voriconazole during continuous high-volume venovenous hemofiltration in a critically ill patient.
Topics: Acute Kidney Injury; Aged; Antifungal Agents; Area Under Curve; Aspergillosis; Critical Illness; Fatal Outcome; Half-Life; Hemofiltration; Humans; Male; Metabolic Clearance Rate; Pyrimidines; Triazoles; Voriconazole | 2008 |
Impact of intravenous administration of voriconazole in critically ill patients with impaired renal function.
Topics: Adult; Aged; Antifungal Agents; Cohort Studies; Critical Illness; Female; Humans; Infusions, Intravenous; Kidney; Liver; Male; Middle Aged; Pyrimidines; Renal Insufficiency; Retrospective Studies; Triazoles; Voriconazole | 2008 |
Voriconazole in newborns.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Critical Illness; Humans; Infant, Newborn; Pyrimidines; Triazoles; Voriconazole | 2008 |